• SENSEX 82,627.00
    571.89 (+0.70%)
  • BANKNIFTY 56,461.90
    402.55 (+0.72%)
  • Garden Reach Sh.
    3,050.00 1,180.10(%)
  • Enviro Infra
    251.85 392.00(%)
  • Waaree Energies
    3,097.15 3,740.75(%)
  • Multi Comm. Exc.
    8,808.85 8,357.25(%)
  • Welspun Living
    142.00 213.10(%)
  • Vodafone Idea
    7.19 19.15(%)
  • Bharat Electron
    409.30 240.15(%)
  • M T N L
    57.90 101.88(%)
  • Cochin Shipyard
    2,120.80 1,180.45(%)
  • Netwrk.18 Media
    61.82 106.01(%)
  • Mazagon Dock
    3,224.45 1,917.95(%)
  • Hind.Aeronautics
    4,800.00 3,045.95(%)
  • Hyundai Motor I
    2,145.00 2,083.60(%)
  • BEML Ltd
    4,422.00 2,346.35(%)
  • Sammaan Capital
    143.85 179.35(%)
  • Vishal Mega Mart
    137.80 134.50(%)
  • Tata Motors
    678.80 1,179.05(%)
  • Dixon Technolog.
    14,090.00 10,613.00(%)
  • Data Pattern
    2,805.00 1,350.50(%)
  • Suzlon Energy
    63.93 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

RPG Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Goenka R P
  • BSE Code : 29175.0
  • ISIN : INE105J01010
2,404.50 -9 (-0.39%)
  • As on 25 Jun 2025 (EOD)

  • Today’s Low

    2,388.80

  • Today’s High

    2,439.90

  • Open

    2,434.00

  • Perv Close

    2,413.90

  • 52W Low

    1,529.05

  • 52W High

    2,974.95

Key Indicators

  • P/E(TTM)

    33.61

  • Mar.Cap (₹Cr.)

    3,976.81

  • Div & Yield %

    1.00

  • Book Value(₹)

    320.78

  • Debt-Equity Ratio

    -0.39

  • AGM Date

    24-Jun-2025

  • EPS

    71.51

  • P/E Ratio

    33.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,976.81

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.23

  • BV (₹)

    320.80

  • Sales( ₹ in Cr.)

    653.43

  • NP (in Cr.)

    118.26

  • NP Var(%)

    36.0

  • Div%

    300.0

  • CPS (₹)

    84.50

  • EPS (₹)

    71.50

  • Traded Value (₹ in Lakhs)

    3,975.23

  • 52 Week High

    2,974.95

  • 52 Week Low

    1,529.05

  • Price BSE

    2404.0

  • Price NSE

    2,405.00

  • Market Capital( in Cr.)

    3,975.23

  • P/C Ratio

    28.50

  • P/E Ratio

    33.60

  • Price Vs.BV

    71.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 582.05 512.81 440.16 389.14 375.57 330.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 582.05 512.81 440.16 389.14 375.57 330.16
Other Income 7.21 4.80 2.99 0.91 0.73 0.80
Stock Adjustments -2.70 7.30 25.21 5.01 5.98 -13.71
Total Income 586.56 524.91 468.36 395.06 382.28 317.25
EXPENDITURE :            
Raw Materials 181.83 178.17 167.03 136.11 133.74 96.33
Power and Fuel Cost 14.36 13.65 12.69 11.27 11.54 10.38
Employee Cost 132.15 117.06 99.97 94.66 90.97 89.93
Other Manufacturing Expenses 26.07 21.60 22.61 18.48 13.72 14.45
Selling and Administration Expenses 80.47 73.63 67.07 58.40 56.84 59.43
Miscellaneous Expenses 15.33 12.47 8.75 4.30 19.90 11.50
Employee Benefit Expenses 132.15 117.06 99.97 94.66 90.97 89.93
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 450.21 416.58 378.12 323.22 326.71 282.02
Operating Profit 136.35 108.33 90.24 71.84 55.57 35.23
Interest 1.44 1.15 1.41 1.79 2.76 4.86
Gross Profit 134.91 107.18 88.83 70.05 52.81 30.37
Depreciation 17.07 15.50 15.66 16.47 16.36 15.32
Profit Before Tax 117.84 91.68 73.17 53.58 36.45 15.05
Current Tax 32.54 24.35 22.76 17.15 10.10 2.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.36 -0.31 -1.07 -3.57 -2.66 1.40
Reported Net Profit 87.66 67.64 51.48 40.00 29.01 10.81
Extraordinary Items 0.77 -0.57 0.61 -0.01 -3.93 -0.04
Adjusted Net Profit 86.89 68.21 50.87 40.01 32.94 10.85
Adjustment below Net Profit -0.56 0.07 -0.25 -0.12 -0.17 -0.27
P & L Balance brought forward 251.23 199.40 160.08 120.20 104.13 98.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 19.85 15.88 11.91 0.00 12.77 4.79
P & L Balance carried down 318.48 251.23 199.40 160.08 120.20 104.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 200.00 150.00 120.00 90.00 50.00 30.00
Dividend Per Share(Rs) 16.00 12.00 9.60 7.20 4.00 2.40
Earnings Per Share-Unit Curr 53.01 40.90 31.13 24.19 17.54 6.54
Earnings Per Share(Adj)-Unit Curr 53.01 40.90 31.13 24.19 17.54 6.54
Book Value 226.67 186.00 154.66 130.88 106.77 97.05
Book Value(Adj)-Unit Curr 226.67 186.00 154.66 130.88 106.77 97.05

Shareholding Pattern

  • Promoter Group

    72.95%

  • Public Share Holding

    27.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,108,771 18.80 3,108,771 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,662 0.22 35,662 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,920,874 53.94 8,920,874 7
Others 0 0.00 0 0
Sub Total 12,065,307 72.95 12,065,307 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,842 0.01 1 6
Foreign Bank 150 0.00 150 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 240,208 1.45 240,208 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 34,660 0.21 34,660 1
Mutual Funds / UTI 583,832 3.53 583,832 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 395,160 2.39 395,160 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,255,852 7.59 1,254,011 64
2] Non Institution
Bodies Corporate 231,756 1.40 230,672 221
Clearing Members 645 0.00 645 3
Directors of their Relatives 1,010 0.01 1,010 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 129,392 0.78 129,120 787
Foreign Non Institution Other 2,850 0.02 0 2
Hindu Undivided Families 133,581 0.81 133,567 488
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 33,327 0.20 33,327 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,502,594 15.13 2,353,937 23,278
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 182,468 1.10 182,468 1
Sub Total 3,217,856 19.46 3,064,746 24,783
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,539,015 100.00 16,384,064 24,867

Company Background

RPG Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • RPG Life Sciences Ltd
  • BSE Code : 29175.0
  • ISIN : INE105J01010

  • Incorporation Year

    2007

  • Registered Office

    RPG House
    463 Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24981650

  • FAX

    91-022-24970127

  • Chairman

    H V Goenka

  • Managing Director

    ASHOK NAIR

  • Company Secretary

    Rajesh Shirambekar

  • Auditor

    SRBC & Co LLP

  • Face Value

    8

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

RPG Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
RPG LifeScience. 2,403.55 589.26 582.05 21.69 34.25
Abbott India 31,510.65 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 8,798.50 1,330.33 1,295.53 190.03 33.26
P & G Health Ltd 5,912.35 1,166.89 1,151.26 39.07 39.76
Glaxosmi. Pharma 3,227.35 3,866.05 3,723.49 59.49 58.72
Cipla 1,502.85 20,029.57 19,044.85 23.53 21.40
Amrutanjan Healt 720.20 437.58 421.23 40.97 20.84
Guj. Themis Bio. 331.75 174.19 169.82 74.05 44.82
Fermenta Biotec. 305.00 315.24 307.09 13.28 4.10
Bliss GVS Pharma 148.60 638.96 605.46 22.69 11.19
Ambalal Sarabhai 35.73 11.70 3.81 33.08 1.92